BANK OF AMERICA CORP /DE/ - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 1 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$05
-92.9%
0.00%
Q4 2021$070
+677.8%
0.00%
Q3 2021$09
-62.5%
0.00%
Q2 2021$024
+84.6%
0.00%
Q1 2021$0130.0%0.00%
Q4 2020$013
-66.7%
0.00%
Q3 2020$039
+200.0%
0.00%
Q2 2020$0
-100.0%
13
-98.8%
0.00%
Q1 2020$2,0001,0650.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q2 2022
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 81,491$116,0000.01%
NewSquare Capital LLC 62$00.00%
UBS Group AG 6,303$9,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 32$00.00%
Jacobi Capital Management LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 39$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 32$00.00%
NORTHERN TRUST CORP 12,751$18,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders